Remove 2014 Remove Concentrates Remove DEA Remove Packaging
article thumbnail

United States: Hemp And CBD Regulation: Beyond Delta-8 THC

Cannabis Law Report

. … and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers … with a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 1005.10); deal with the types of products that can, and cannot, be sold in New York (§1005.8); and establish packaging and labeling standards (§1005.9).

THC 105
article thumbnail

CBD Oracle Lab Study Shows Some Delta-8 Products Are 7700% Over the Legal Delta-9 THC Limit

Cannabis Law Report

The products included flower, edibles, prerolls, tinctures, concentrates, vape cartridges and vape pens, and were mainly purchased online from various states. Illegal Delta-9 Levels More Likely in Vapes and Concentrates: Vapes and concentrates generally contained higher levels of delta-9 THC than flower, tinctures or edibles.

THC 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis Industry Leaders Speak With CLR on Current Delta 8 Issues In The Industry

Cannabis Law Report

We believe there is a benefit to Delta-8 but there should be labeling or warnings on packages so that consumers are informed of potential minor intoxication effects. As a graduate student, he received the IPMI Richard Rubin Memorial Scholarship in 2014 for his research in precious metals. D8 may well assist with relaxation and sleep.

article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

The AAFP advocates for robust regulation regarding labeling and child-proof packaging of all marijuana and cannabinoid products. However, CB1 is most concentrated in the neural tissues. 14 Vaping marijuana and CBD concentrates are an increasingly popular inhalation method.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

The most common side effects reported were somnolence (25%), decreased appetite (19%) diarrhea, (19%) Fatigue, (13%) Elevated liver enzymes, (7%) Convulsion, (11%) Increased appetite, (9%) Status epilepticus, (8%) Lethargy, (7%) Weight increased, (7%) Weight decreased, (6%) Drug concentration increased, (6%). 32: United States DEA.